Concepedia

Michael T. Leach

MT

Statistics

Publications

4

Citations

178

H-Index

4

Active since

2011

Affiliations

Gartnavel General Hospital(Current)

University of Glasgow

Royal Alexandra Hospital

Michael T. Leach is an author at Gartnavel General Hospital specializing in tumor microenvironment, oncology, and tumor biology.

Top concepts

Publications per year

2011–2018

4

Publications

4

Dasatinib inhibits B cell receptor signalling in chronic lymphocytic leukaemia but novel combination approaches are required to overcome additional pro‐survival microenvironmental signals

Alison M. McCaig, Emilio Cosimo, Michael T. Leach et al. · British Journal of Haematology · 2011 · 81 citations · Full text

Dasatinib Inhibits CXCR4 Signaling in Chronic Lymphocytic Leukaemia Cells and Impairs Migration Towards CXCL12

Alison M. McCaig, Emilio Cosimo, Michael T. Leach et al. · PLoS ONE · 2012 · 33 citations · Full text

, , +14

Inhibition of NF-κB–Mediated Signaling by the Cyclin-Dependent Kinase Inhibitor CR8 Overcomes Prosurvival Stimuli to Induce Apoptosis in Chronic Lymphocytic Leukemia Cells

Emilio Cosimo, Alison M. McCaig, Luke J.M. Carter-Brzezinski et al. · Clinical Cancer Research · 2013 · 32 citations · Full text

AKT/mTORC2 Inhibition Activates FOXO1 Function in CLL Cells Reducing B-Cell Receptor-Mediated Survival

Emilio Cosimo, Anuradha Tarafdar, Michael W. Moles et al. · Clinical Cancer Research · 2018 · 32 citations · Full text

1–4 of 4